The novel IV antibiotic combination works ‘synergistically’ to combat gram-negative pathogens in complicated UTIs and pyelonephritis.
Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs). In clinical trials, ...
Add Yahoo as a preferred source to see more of our stories on Google. UTIs are caused by bacteria like E. coli. But some infections are resistant to antibiotics. (Science Photo Library via Getty ...
Bacteria cause urinary tract infections (UTIs), so antibiotics are the first-line treatment. Even when symptoms disappear, a person should finish their antibiotic course according to their doctor’s ...
The U.S. Food and Drug Administration just approved the first new antibiotic to treat urinary tract infections in nearly three decades. UTIs are infections in any part of the urinary system and affect ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved gepotidacin (Blujepa, GSK), a new oral antibiotic for uncomplicated urinary tract infections (UTIs) in females aged 12 years ...
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results